Gadobutrol Magnevist-controlled Body Study

NCT01050829 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

370

Enrollment

INDUSTRY

Sponsor class

Conditions

Magnetic Resonance Imaging

Interventions

DRUG: Gadobutrol (Gadovist, BAY86-4875)
DRUG: Gadopentetate Dimeglumine (Magnevist, BAY86-4882)

Sponsor

Bayer